| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/21/2004 | CN1491225A Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as active ingredient |
| 04/21/2004 | CN1491224A 5-[4-[2(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione mesylate salt |
| 04/21/2004 | CN1491223A 3-indoline derivatives useful in treatment of psychiatric and neurologic disorders |
| 04/21/2004 | CN1491222A Piperidinee derivatives as neurokinin/antagonists |
| 04/21/2004 | CN1491221A Thiophene substituted amine derivatives as GLYT-1 inhibitors |
| 04/21/2004 | CN1491220A Lactone compound as novel photoinitiators |
| 04/21/2004 | CN1491216A Novel alkyl phenylimino-imidazolidine derivatives for treating urinary incontinence |
| 04/21/2004 | CN1491213A Novel benzoylguanidine salt |
| 04/21/2004 | CN1491208A Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 04/21/2004 | CN1491207A Acylated indanyl amines and their use as pharmaceuticals |
| 04/21/2004 | CN1491206A Malic acid addition salts of terbinafine |
| 04/21/2004 | CN1491126A Method of cancer therapy |
| 04/21/2004 | CN1491125A Use of flumazenil to produce medicament for treatment of cocaine dependency |
| 04/21/2004 | CN1491112A Use of type 4 phosphodiesterase inhibitors in myocardial diseases |
| 04/21/2004 | CN1491111A Antiviral method of use |
| 04/21/2004 | CN1491110A Medical composition for treatment of chronic cardiac failure |
| 04/21/2004 | CN1491109A Medical compositions containing aspirin |
| 04/21/2004 | CN1491108A Antifungal remedy formulation for external application |
| 04/21/2004 | CN1491107A Use of compound for treating tinnitus |
| 04/21/2004 | CN1491106A Treatment of oesophageal motility disorders and gastro-oesophageal reflux disease |
| 04/21/2004 | CN1491105A Novel modified released formulation |
| 04/21/2004 | CN1491104A Novel modified release formulation |
| 04/21/2004 | CN1491089A Composition and method for smoke detoxification |
| 04/21/2004 | CN1491085A Food product comprising soy protein and statins |
| 04/21/2004 | CN1490326A Triterpenoid saponin in stem and leaf of American ginseng and its medicinal use and preparation |
| 04/21/2004 | CN1490322A Ansi glycoside compound and its medicinal composition, preparation and use |
| 04/21/2004 | CN1490321A Effective parts of fructus sophorae flavone production and use thereof |
| 04/21/2004 | CN1490308A Acylhydrazone compound, preparing method and use thereof |
| 04/21/2004 | CN1490056A Immune method and composition for HIV-1 |
| 04/21/2004 | CN1490054A Targeted anticarious DNA vaccine and peparation thereof |
| 04/21/2004 | CN1490048A Method for improving oral drug living thing availability, composition and reagent box |
| 04/21/2004 | CN1490045A Sisal hemp extractive, preparing method and use thereof |
| 04/21/2004 | CN1490016A Bougie for treating virus hepatitis and preparing method thereof |
| 04/21/2004 | CN1490015A Thevina drops and preparation thereof |
| 04/21/2004 | CN1490014A Mangiferin preparation and production thereof |
| 04/21/2004 | CN1490013A Health products |
| 04/21/2004 | CN1490012A Zine glycyrrhizate drops and preparation thereof |
| 04/21/2004 | CN1490011A Methanesulfonic pazuthacin injection and its preparing process against infection |
| 04/21/2004 | CN1490010A Methanesul fonic pazuthacin injection and its preparing process against infection |
| 04/21/2004 | CN1490009A Sustained release injection containing medicine against coccindian |
| 04/21/2004 | CN1490008A Minlpress hydrochloride drops and preparation thereof |
| 04/21/2004 | CN1490007A Quinoline coridalis B drops and preparation thereof |
| 04/21/2004 | CN1490006A Melazocine masticatory and its preparation |
| 04/21/2004 | CN1490005A Berberine or berberine salts drops and their preparation |
| 04/21/2004 | CN1490004A Freeze-dried tinidazole preparation and preparing method thereof |
| 04/21/2004 | CN1490003A Treatment of oral lichen planus |
| 04/21/2004 | CN1490002A Enalapril drops and preparation thereof |
| 04/21/2004 | CN1490001A Hepadestal drops and preparation thereof |
| 04/21/2004 | CN1490000A Hippophae rhamnoide flavone drops and preparation thereof |
| 04/21/2004 | CN1489999A Use of tanshinone in therapeutic medicines for abnormal hyperplasia of vascular smooth muscle cells |
| 04/21/2004 | CN1489998A Isosorbide dinitrate drops and preparation thereof |
| 04/21/2004 | CN1489997A Anticancer nutritive Chinese medicine |
| 04/21/2004 | CN1489996A Diclofenac sodium pastes and preparation thereof |
| 04/21/2004 | CN1489995A Amitriptyline hydrochloride drops and preparation thereof |
| 04/21/2004 | CN1489994A Extracts of fat soluble benzyl ethene contents from curcuma longa and use in preparation |
| 04/21/2004 | CN1489993A Use of archin and extracts containing archin in recovery of enterogastric functions after operation and prevention of intestinal edhension |
| 04/21/2004 | CN1146665C Method of modulating melanin synthesis |
| 04/21/2004 | CN1146573C Novel arabinosyladenine derivatives |
| 04/21/2004 | CN1146568C Novel cyano-indole thrombotonin reuptaking inhibitor compound, its preparation process and medicinal compositions having the same |
| 04/21/2004 | CN1146567C 奥氮平二水合物d Olanzapine dihydrate d |
| 04/21/2004 | CN1146566C 2-aryl-8-oxodihydropurine derivatives, process for producing same, medicinal conty, same, and intermediates thereof |
| 04/21/2004 | CN1146565C Polymorphs of crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions |
| 04/21/2004 | CN1146564C Antibiotic sultam and sultone drived oxazolidiones |
| 04/21/2004 | CN1146563C Piperidinylmethyloxazolidinone derivative |
| 04/21/2004 | CN1146562C Thtraphydrothiopy 2,3-diazanaphthylaone derivatives as PDE4 inhibitors |
| 04/21/2004 | CN1146559C Muscarinic antagonists |
| 04/21/2004 | CN1146558C Novel salt form of pantoprazole |
| 04/21/2004 | CN1146557C Process for prepn. of 1-type sodium-hydrogen exchange agent inhibitor |
| 04/21/2004 | CN1146556C 1,2-dihydroindene or indoline derivatives, preparation and use thereof |
| 04/21/2004 | CN1146554C Enantioeletive synthesis of nonsteroidal antiestrogen |
| 04/21/2004 | CN1146553C Hydroxymatatairesinol in cancer prevention |
| 04/21/2004 | CN1146552C Azulene hydroxamic acid derivatives as metalloprotein inhibitors |
| 04/21/2004 | CN1146551C Substituted diazacycloheptane compound, medicine composition contg, same and the use thereof |
| 04/21/2004 | CN1146549C Sulphenylxazolamines as therapeutic active ingredients |
| 04/21/2004 | CN1146545C Benzoylpyridazines |
| 04/21/2004 | CN1146544C Pyrazoelcarboxylic acid derivatives, their preparation, pharmaceutical compositions containing |
| 04/21/2004 | CN1146543C Serine protease inhibitor |
| 04/21/2004 | CN1146542C Benzamide derivatives and their use as cytokine inhibitors |
| 04/21/2004 | CN1146541C Beta-alanine derivatives |
| 04/21/2004 | CN1146540C Novel compound with analgesic effect and use thereof |
| 04/21/2004 | CN1146538C Process for preparation of zofenopril calcium salt |
| 04/21/2004 | CN1146537C Dofetilide polymorphs |
| 04/21/2004 | CN1146536C Cycloethylene derivatives |
| 04/21/2004 | CN1146455C 1,2,4,5-tetrahydro-benzo[d] azepine compound |
| 04/21/2004 | CN1146441C Composition of containing lympha toxin beta receptor |
| 04/21/2004 | CN1146438C External use medicine bag for stagnation-syndrome |
| 04/21/2004 | CN1146430C Methods of decreasing or preventing pain using spicamycin or derivatives thereof |
| 04/21/2004 | CN1146429C Phospholipid complexes of proanthocyanidin A2 used as antiatherosclerotic agent |
| 04/21/2004 | CN1146428C Crystallized pirimiphos-methyl composite and its preparation and usage |
| 04/21/2004 | CN1146427C Solid oral dosage form comprising combination of metformin and glibenclamide |
| 04/21/2004 | CN1146426C Stable aspirin-containing preparations for external use |
| 04/21/2004 | CN1146425C Application of peimin A in preparing medicine to treat drug-resistant bacterial infective diseases |
| 04/21/2004 | CN1146424C Stabilized tibolone compositions |
| 04/21/2004 | CN1146423C Prostaglandin product |
| 04/21/2004 | CN1146422C 2-methyl-thieno-benzodiazepine formulation |
| 04/21/2004 | CN1146421C Composition for treating pains and use of medicines in preparation thereof |
| 04/21/2004 | CN1146420C Use of [R-(2)-alpha-(methoxylimino)-alpha-(1-azabicyclo[2,2,2]octa-3- radicle)-acetonitrile in preparation of medicine for psychoses |
| 04/21/2004 | CN1146419C Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants |
| 04/21/2004 | CN1146418C Fixed-dose association of angiotensin-converting enzyme inhibitor and of calcium channel antagonist, method for preparation and use thereof in treatment of cardivas cular illnesses |
| 04/21/2004 | CN1146417C Stabilized pharmaceutical compositions, with quinupristine and dalfopristine base and their prepn |